London
11 °C
Manchester
7 °C
Glasgow
Dublin
Belfast
Washington
Denver
-1 °C
Atlanta
9 °C
Dallas
Houston Texas
10 °C
New Orleans
13 °C
El Paso
Phoenix
Los Angeles
16 °C
-16 °C
4 °C
28 °C
Johnson & Johnson temporarily halts Covid-19 vaccine output: report / Photo: ©
NYSE - LSE
| SCS | 0.12% | 16.14 | $ | |
| CMSC | -0.55% | 23.53 | $ | |
| RBGPF | 0.12% | 82.5 | $ | |
| BCC | 4.46% | 88.895 | $ | |
| NGG | 1.49% | 87.53 | $ | |
| JRI | 0.36% | 13.167 | $ | |
| AZN | 2.06% | 188.19 | $ | |
| CMSD | -0.34% | 23.86 | $ | |
| GSK | 6.17% | 56.845 | $ | |
| RIO | -0.9% | 95.515 | $ | |
| BCE | 1.02% | 26.37 | $ | |
| RYCEF | -1.19% | 16.8 | $ | |
| BTI | -0.59% | 61.51 | $ | |
| RELX | -1.8% | 29.97 | $ | |
| BP | 0.63% | 39.065 | $ | |
| VOD | 2.18% | 15.59 | $ |
Johnson & Johnson temporarily halts Covid-19 vaccine output: report
Johnson & Johnson has temporarily suspended production at a key plant manufacturing the Covid-19 vaccine, the New York Times reported Tuesday.
The facility in the Dutch city of Leiden halted output late last year, according to the report, which cited people familiar with the decision.
J&J, without confirming or denying the report, said it has continued to fulfill delivery commitments, a company spokesman said.
The factory, which is currently making an experimental vaccine, is expected to resume production of the Covid-19 vaccine again in a "few" months, the Times reported.
J&J currently has "millions of doses of our Covid-19 vaccine in inventory," according to the J&J spokesman.
"We continue to fulfill our contractual obligations in relation to the Covax facility and the African Union," the company spokesman said.
J&J has projected sales of $3 billion to $3.5 billion in 2022 for its Covid-19 vaccine, much less than the $32 billion forecast by Pfizer for the same period.
But the J&J vaccine has been sought after in developing countries because, unlike other options, it does not require transportation at very cold temperatures. Also, the vaccine was originally billed as a single-shot inoculation.
Additional plants are being outfitted to make the vaccine, but production is not expected until late spring, the Times said.
L.M. Cardoso--JDB
